Search

Borregaard ASA

Fermé

207

Résumé

Variation du prix de l'action

24h

Actuel

Min

206

Max

208.5

Chiffres clés

By Trading Economics

Revenu

4M

255M

Ventes

9M

2B

P/E

Moyenne du Secteur

23.198

73.407

BPA

2.56

Rendement du dividende

2.03

Marge bénéficiaire

12.469

Employés

1,174

EBITDA

505M

Dividendes

By Dow Jones

Rendement du dividende

Moyenne du Secteur

2.03%

5.87%

Prochains Résultats

22 oct. 2025

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

349M

21B

Ouverture précédente

207

Clôture précédente

207

Borregaard ASA Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

9 sept. 2025, 23:37 UTC

Actions en Tendance

Stocks to Watch: Oracle, Wearable Devices, GameStop

9 sept. 2025, 20:41 UTC

Résultats

Oracle's Backlog Surges With Major Customer Deals in 1Q

9 sept. 2025, 20:30 UTC

Résultats

GameStop 2Q Sales, Profit Rise

9 sept. 2025, 23:19 UTC

Market Talk

ANZ Adds a Further 50 Bps in FOMC Cuts to Outlook -- Market Talk

9 sept. 2025, 21:35 UTC

Résultats

Oracle Stock Soars on Strong AI Backlog. Earnings Were Good Enough. -- Barrons.com

9 sept. 2025, 21:32 UTC

Résultats

Oracle's Backlog Swells With Big Customer Deals -- Update

9 sept. 2025, 21:02 UTC

Acquisitions, Fusions, Rachats

DHL Adds to Healthcare Logistics Services With Acquisition -- Update

9 sept. 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

9 sept. 2025, 20:33 UTC

Résultats

These Stocks Moved the Most Today: Apple, UnitedHealth, Nebius, Wolfspeed, Tourmaline Bio, Albemarle, Dell, and More -- Barrons.com

9 sept. 2025, 20:26 UTC

Résultats

Oracle Stock Soars on Strong Backlog. Earnings Were Good Enough. -- Barrons.com

9 sept. 2025, 20:23 UTC

Résultats

Oracle Stock Soars on Strong Backlog. Earnings Were Good Enough. -- Barrons.com

9 sept. 2025, 20:12 UTC

Résultats

Oracle Stock Jumps on Mixed Earnings Report -- Barrons.com

9 sept. 2025, 20:10 UTC

Résultats

Oracle Expects Cloud Infrastructure Rev to Grow 77% to $18 B This Fiscal Yr >ORCL

9 sept. 2025, 20:10 UTC

Résultats

Oracle Expects to Sign-Up Several Additional Multi-B-dollar Customers and RPO Is Likely to Exceed Half-A-Trillion Dollars Over Next Few Mos

9 sept. 2025, 20:09 UTC

Résultats

Synopsys Sees 4Q Adj EPS $2.76-Adj EPS $2.80 >SNPS

9 sept. 2025, 20:09 UTC

Résultats

Synopsys Sees 4Q Loss/Shr 16c-Loss 27c >SNPS

9 sept. 2025, 20:08 UTC

Résultats

Oracle 1Q Short-term Deferred Rev Were $12.1 B >ORCL

9 sept. 2025, 20:08 UTC

Résultats

Oracle 1Q Operating Income Was $4.3 B >ORCL

9 sept. 2025, 20:08 UTC

Résultats

Oracle Expects MultiCloud Rev to Grow Substantially Every Qtr for Several Years >ORCL

9 sept. 2025, 20:08 UTC

Résultats

Synopsys Sees 4Q Rev $2.23B-$2.26B >SNPS

9 sept. 2025, 20:07 UTC

Résultats

Oracle Total Remaining Performance Obligations Up to $455 B >ORCL

9 sept. 2025, 20:06 UTC

Résultats

Oracle 1Q Software Revenue $5.72B >ORCL

9 sept. 2025, 20:06 UTC

Résultats

Synopsys 3Q Adj EPS $3.39 >SNPS

9 sept. 2025, 20:06 UTC

Résultats

Oracle 1Q Cloud Revenue $7.19B >ORCL

9 sept. 2025, 20:05 UTC

Résultats

Oracle 1Q Rev $14.93B >ORCL

9 sept. 2025, 20:05 UTC

Résultats

Oracle 1Q EPS $1.01 >ORCL

9 sept. 2025, 20:05 UTC

Résultats

Synopsys 3Q EPS $1.50 >SNPS

9 sept. 2025, 20:05 UTC

Résultats

Oracle 1Q Services Revenue $1.35B >ORCL

9 sept. 2025, 20:05 UTC

Résultats

Oracle 1Q Adj EPS $1.47 >ORCL

9 sept. 2025, 20:05 UTC

Résultats

Oracle 1Q Hardware Revenue $670M >ORCL

Borregaard ASA prévision

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Borregaard ASA

Borregaard ASA engages in the development, production, and marketing of specialized biomaterials and biochemicals in Norway, rest of Europe, the United States, Asia, and internationally. It operates in three segments: BioSolutions, BioMaterials, and Fine Chemicals. The BioSolutions segment develops, produces, and sells biopolymers for various applications, such as agrochemicals, batteries, industrial binders, and construction; and biovanillin for flavor and fragrance companies, as well as for food and beverage industry. The BioMaterials segment offers specialty cellulose for use as a raw material in the production of cellulose ethers, cellulose acetate, and other specialty products; and cellulose fibrils for industrial applications. The Fine Chemicals segment provides fine chemical intermediates for contrast agents; and advanced bioethanol products. Borregaard ASA was incorporated in 2012 and is headquartered in Sarpsborg, Norway.
help-icon Live chat